Matloob Ahmad

Dr. Matloob Ahmad

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2016 in Synthetic Communications
Verified
Journal Article
Closed access
FSFurqan Ahmad Saddique
Furqan Ahmad Saddique
AZAmeer Fawad Zahoor
Ameer Fawad Zahoor
SFSadia Faiz
Sadia Faiz
SNSyed Ali Raza Naqvi
Syed Ali Raza Naqvi
MUMuhammad Usman
Muhammad Usman
MAMatloob Ahmad
Matloob Ahmad
β-Amino alcohols are versatile intermediates in the synthesis of various biologically potent compounds, which can also be achieved by ring opening of epoxides by amines. In the present review, focus has been placed on the ring opening of epoxides with amines under a variety of reaction parameters reported during 2011–2015. All the factors that resulted in excellent yields and high regioselectivity, are environmentally benign, and use mild conditions have been discussed in detail. In addition, the applications of these methods in the synthesis of biologically active compounds such as β-blockers have also been described.

1 February 2010 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MAMatloob Ahmad
Matloob Ahmad
HSHamid Latif Siddiqui
Hamid Latif Siddiqui
MRMuhammad Zia Ur Rehman
Muhammad Zia Ur Rehman
MPMasood Parvez
Masood Parvez

15 June 2019 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
AKAfshan Kanwal
Afshan Kanwal
MAMatloob Ahmad
Matloob Ahmad
SASana Aslam
Sana Aslam
SNSyed Ali Raza Naqvi
Syed Ali Raza Naqvi
MSMuhammad Jawwad Saif
Muhammad Jawwad Saif

26 November 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
NMNoor Ul Amin Mohsin
Noor Ul Amin Mohsin
SASana Aslam
Sana Aslam
MAMatloob Ahmad
Matloob Ahmad
Muhammad IrfanMuhammad Irfan
Muhammad Irfan
SASami A. Al-Hussain
Sami A. Al-Hussain
MZMagdi Zaki
Magdi Zaki
Cancer is a serious threat to human beings and is the second-largest cause of death all over the globe. Chemotherapy is one of the most common treatments for cancer; however, drug resistance and severe adverse effects are major problems associated with anticancer therapy. New compounds with multi-target inhibitory properties are targeted to surmount these challenges. Cyclooxygenase-2 (COX-2) is overexpressed in cancers of the pancreas, breast, colorectal, stomach, and lung carcinoma. Therefore, COX-2 is considered a significant target for the synthesis of new anticancer agents. This review discusses the biological activity of recently prepared dual anticancer and COX-2 inhibitory agents. The most important intermolecular interactions with the COX-2 enzyme have also been presented. Analysis of these agents in the active area of the COX-2 enzyme could guide the introduction of new lead compounds with extreme selectivity and minor side effects.

12 March 2018 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
AKAfshan Kanwal
Afshan Kanwal
FSFurqan Ahmad Saddique
Furqan Ahmad Saddique
SASana Aslam
Sana Aslam
MAMatloob Ahmad
Matloob Ahmad
AZAmeer Fawad Zahoor
Ameer Fawad Zahoor
NMNoor-Ul-Amin Mohsin
Noor-Ul-Amin Mohsin

1 May 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SASana Aslam
Sana Aslam
SZSumera Zaib
Sumera Zaib
MAMatloob Ahmad
Matloob Ahmad
JGJohn M. Gardiner
John M. Gardiner
AAAqeel Ahmad
Aqeel Ahmad
JIJamshed Iqbal
Jamshed Iqbal